www.loltestab.fora.pl
Just a simple test
FAQ
Search
Memberlist
Usergroups
Galleries
Register
Profile
Log in to check your private messages
Log in
www.loltestab.fora.pl Forum Index
->
Forum testowe
Post a reply
Username
Subject
Message body
Emoticons
View more Emoticons
Font colour:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Indigo
Violet
White
Black
Font size:
Tiny
Small
Normal
Large
Huge
Close Tags
Options
HTML is
OFF
BBCode
is
ON
Smilies are
ON
Disable BBCode in this post
Disable Smilies in this post
Confirmation code: *
All times are GMT + 2 Hours
Jump to:
Select a forum
Jakaś kategoria
----------------
Forum testowe
Topic review
<table border="0" cellpadding="3" cellspacing="1" width="100%" class="forumline"> <tr> <th class="thCornerL" width="22%" height="26">Author</th> <th class="thCornerR">Message</th> </tr> <tr> <td width="22%" align="left" valign="top" class="row1"><span class="name"><a name=""></a><b>cheapbag214s</b></span></td> <td class="row1" height="28" valign="top"><table width="100%" border="0" cellspacing="0" cellpadding="0"> <tr> <td width="100%"><img src="http://picsrv.fora.pl/subSilver/images/icon_minipost.gif" width="12" height="9" alt="Post" title="Post" border="0" /><span class="postdetails">Posted: Thu 3:20, 28 Nov 2013<span class="gen"> </span> Post subject: Lack of antibiotics for superbugs in development</span></td> </tr> <tr> <td colspan="2"><hr /></td> </tr> <tr> <td colspan="2"><span class="postbody">Report: Lack of antibiotics for superbugs in development <br />WASHINGTON, April 18 () -- The current pipeline of antibiotics is fragile and the dwindling roster of antibiotic developers has dire consequences for public health, U.S. experts say. Dr. Henry Chambers, chairman of Infectious Diseases Society of America's Antimicrobial Resistance Committee, said at this urgent time of greatest need, the number of pharmaceutical companies investing in antibiotic research and development plummeted.In a report, published online in the Clinical Infectious Diseases, IDSA identified only seven new drugs in development for the treatment of infections caused by multi-drug-resistant gram-negative bacilli bacteria -- superbugs. Pharmaceutical companies typically put research and development resources into the development of chronic disease drugs -- including those to treat high cholesterol, diabetes and cancer -- which provide significant financial rewards, partly because they are intended to be taken for long periods of time, Chambers said. Antibiotics, which are intended to be taken for short period of time, can't compete,[url=http://www.parajumpersjackenoutlet.de/]parajumpers jacken outlet[/url], Chambers said. The results are playing out in real time, with a smaller pharmaceutical company, Polymedix, which has one of the seven drugs in development, filing for bankruptcy protection in early April 2013,[url=http://www.christianlouboutinonlineshop.de/]christian louboutin schuhe[/url], the report said. Moreover, the policy update reports only four large multi-national companies remain in antibiotic research and development. One of these, AstraZeneca, which has two of the seven drugs in development, plans to reduce its future investments in antibiotics, Pascal Soriot, it's chief executive officer said recently. The IDSA first warned of the looming antibiotic apocalypse with its 2004 report, "Bad Bugs, No Drugs."</span></td> </tr> </table></td> </tr> <tr> <td colspan="2" height="1" class="spaceRow"><img src="http://picsrv.fora.pl/subSilver/images/spacer.gif" alt="" width="1" height="1" /></td> </tr> </table>
fora.pl
- załóż własne forum dyskusyjne za darmo
Powered by
phpBB
© 2001, 2005 phpBB Group
Regulamin
FAQ
Search
Memberlist
Usergroups
Galleries
Register
Log in to check your private messages
Log in